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Abstract The prevalence of vesicoureteral reflux (VUR),
although reported to be low in the general population, is
high in children with urinary tract infection (UTI), first
degree relatives of patients with known VUR and children
with antenatal hydronephrosis. In addition, it has been
shown that VUR and UTIs are associated with renal
scarring, predisposing to serious long-term complications,
i.e., hypertension, chronic renal insufficiency and compli-
cations of pregnancy. Therefore, diagnostic imaging for the
detection of VUR in the high-risk groups of children has
been a standard practice. However, none of these associa-
tions has been validated with controlled studies, and
recently the value of identifying VUR after a symptomatic
UTI has been questioned. In addition, several studies have
shown that renal damage may occur in the absence of VUR.
On the other hand, some patients, mainly males, may have
primary renal damage, associated with high-grade VUR,
without UTI. Recently, increasing skepticism has been
noted concerning how and for whom it is important to
investigate for VUR. It has been suggested that the absence
of renal lesions after the first UTI in children may rule out
VUR of clinical significance and reinforces the redundancy
of invasive diagnostic techniques. Therefore, the priority of
imaging strategies should focus on early identification of
renal lesions to prevent further deterioration.
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Introduction
Urinary tract infection (UTI) is relatively common in young
children and occurs in 2.2% for boys and 2.1% for girls
younger than 2 years [1]. The prevalence of UTI in girls
increases in older children, and it has been estimated that
8.4% of girls and 1.7% of boys will develop at least one
UTI by the age of 7 years [2]. It has been long recognized
that UTI is a marker for abnormalities of the urinary tract,
the most common problem being primary vesicoureteral
reflux (VUR). The prevalence of VUR is 30% to 40% in
children with UTI and appears to decrease with age [3]. It is
also diagnosed in 9% to 11% of neonates with antenatal
hydronephrosis [4, 5], in 32% of siblings [6] and in 66% of
offspring of known VUR patients [7]. In contrast, the
incidence of VUR in healthy children was less than 2% in
studies conducted between the 1950s and the 1970s [8].
This association led to the concept that VUR played a
significant role in the pathogenesis of UTIs, acute pyelo-
nephritis (APN) and renal scarring and has been the basis
for diagnostic procedures [9]. However, none of these
associations have been validated with controlled studies. In
addition, a significantly higher prevalence of VUR in
normal population has been calculated from epidemiolog-
ical data of children without UTI [10]. If these doubts are
correct, it would argue against the clinical significance of
VUR and the routine use of voiding cystourethrography
(VCUG).
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Considerations for planning the investigation for VUR
Coarse renal scarring of one or both kidneys is associated
with VUR and UTI and is called reflux nephropathy (RN)
[11]. Fortunately, RN is much less common than VUR and
UTI, although potentially more serious. In the past, children
with RN were considered to be at risk for recurrent
infections and long-term problems, such as hypertension,
chronic renal insufficiency (CRI) and complications of
pregnancy [12]. However, no distinction was made between
children with UTI, VUR and primary scars and UTI, VUR
and secondary scars. This distinction is very important,
because CRI occurs in the first group and is almost never
seen in the second (at least in childhood). The main role of
diagnostic imaging in UTI is to identify the children with a
high risk for developing RN. Increasing skepticism has
been noted recently concerning when and for whom it is
important to investigate for VUR. This is mainly the result
of a systematic review of recent publications made based on
patients with RN that revealed the following information.
Primary and secondary reflux nephropathy
Data from studies in newborns with VUR detected in the
investigation of fetal hydronephrosis documented the
presence of congenital renal damage in the absence of
UTI [4, 5, 13]. Actually, most of the severely affected
kidneys had no exposure to UTI (85%) [13]. Their primary
renal damage is usually associated with higher grades of
VUR [14], and both findings may be the result of
embryonal abnormality of the ureteral bud. These patients
with congenital anomalies of the kidney and urinary tract
(CAKUT) are mainly boys with global parenchymal
reduction, i.e., small kidneys without focal scars. Renal
hypo-dysplasia is characterized by a reduction in nephron
number, a small overall kidney size and/or disturbed
organization of the renal tissue with lack of corticomedul-
lary differentiation and the presence of cysts that, on
occasion, massively distend the organ [15]. In a recent
study, mutations or variants in five important renal
developmental genes that are associated with syndromal
renal malformations were detected in 17% of children who
presented with renal hypo-dysplasia and CRI [16]. This
percentage is expected to increase in the future, when
mutation analysis of genes for which renal maldevelopment
has been demonstrated in genetically modified animal
models will be performed.
Children with primary renal damage should be distin-
guished from the secondary RN, which is the result of
recurrent febrile UTIs and occurs mainly in girls of older
age. Children with secondary RN have normal kidneys
initially, and segmental scarring is usually diagnosed after
infancy. Recurrent UTI is the most important pathogenetic
factor for acquired renal scarring [12] (Fig. 1). Although the
presence of moderate to severe VUR remains a significant
risk factor for renal scarring [17], often renal scarring is
associated with no or low-grade VUR [18, 19]. Unfortu-
nately, it is not always possible to distinguish primary and
secondary lesions with a renal cortical scintigraphy with
technetium 99m dimercaptosuccinic acid (DMSA) scan.
There is evidence that some renal scars associated with
high-grade VUR that have been considered to be secondary
may actually represent primary fetal nephropathy [20].
Therefore, acquired RN can only be documented if a
DMSA has been done before and after an APN.
Fig. 1 a DMSA scan of a 2-year-old girl with persistent, bilateral
grade II VUR and dysfunctional voiding 6 months after the first
documented febrile UTI. A smaller size of right kidney is demon-
strated, compared to the left kidney with focal and generalized
reduction in radiotracer uptake in the poles and indentation of the
renal contour. The left kidney also presents a lack of homogeneity in
DMSA uptake, mainly in the lower pole. b A DMSA scan 9 years
later, after stopping the follow-up and antibiotic prophylaxis on the
family’s own initiative and after breakthrough UTIs. The right kidney
demonstrates further reduction of the size, and new scars are seen in
both kidneys
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Bladder dysfunction and VUR
Several studies have reported a high frequency of bladder
dysfunction (bladder instability and detrusor-sphincter
dyscoordination) in children with VUR [21]. Children with
bladder instability are characterized by sphincter constric-
tions during bladder filling in order to maintain continence
during a contraction of the bladder. These patients have
symptoms of incontinence, urgency and frequency. They
usually have low or no residual volume. In contrast, the
characteristic of children with dyscoordinated bladder is
obstruction during voiding. This is a much more serious
problem; however, recently milder forms have been
described. These children usually have urgency, diurnal
and nocturnal incontinence, interrupted voiding and fre-
quent UTIs [21]. They also often have high bladder
capacity (greater than twice the expected normal value for
age) and high residual urine (greater than 20% of bladder
capacity) [22].
Bladder dysfunction is frequently unrecognized and is
associated with delayed VUR resolution and an increased
rate of breakthrough UTI [23]. It is of interest that after the
disappearance of VUR, UTIs occurred in 26% of children
with dysfunctional voiding. It was suggested that the
appropriate evaluation and management of this problem
should be an integral part of the treatment of every child
with VUR [23]. It was also recently proposed that VUR is a
heterogeneous disease and in some patients should be
regarded as a marker of a combination of disorders that
include primary renal lesions, altered urinary bladder
function and a predisposition to UTI [9].
VUR as a predictor of renal damage
APN may occur in the absence of demonstrable VUR [24],
and once it has occurred, ultimately renal scarring is
independent of the presence or absence of VUR [25, 20].
Actually, in a recent multicenter study permanent renal
damage was diagnosed in 52% of children without VUR
[26]. The investigation of these patients with a DMSA scan,
despite the negative findings on the VCUG, may possibly
lead to the prevention of long-term complications. These
children may have primary renal damage with no VUR, or
VUR could have spontaneously resolved before the UTI
that prompted the imaging studies. Another possibility is
that some bacteria access renal parenchyma from the
urinary bladder either by direct ascent or by hematogenous
spread [27]. Finally under-diagnosis of VUR by VCUG is
well documented in studies with radionuclide cystography
(RNC) [17].
In a recent meta-analysis it was found that a positive
VCUG increased the risk of renal damage by about 20%,
whereas a negative VCUG increased the chance of no renal
involvement by just 8% [27]. In addition, an abnormal
DMSA was found only in 16% of children with VUR aged
less than 1 year with a normal renal ultrasound (US), and
50% of scarred kidneys did not have associated VUR [28].
It is also documented that a normal DMSA scan after the
first UTI can exclude VUR of clinical significance
irrespective of age and infection characteristics [29]. It is
of interest that after 1 year of follow-up monitoring, mild/
moderate VUR does not increase the incidence of UTI,
APN or renal scarring after APN [30]. However, in another
recent study it was found that 40% of children with VUR
had persistent renal parenchymal defects on a DMSA scan
performed 6 months after the last febrile UTI. In contrast,
renal lesions were found in only 6% of subjects without
VUR with at least two febrile UTIs or one febrile UTI
whose antibacterial treatment was started more than 4 days
after the onset of fever. The higher prevalence of persistent
renal defects in this study was explained as the result of the
higher age of the patients (50% of them were over 2 years
of age) with the possible accumulation of scars from
previous APN [17].
It has been long recognized that the chance of
developing RN is much higher in younger children, with
babies at greatest risk [31]. In addition, children with
normal US and DMSA scan after a UTI have a negligible
risk of developing a scar after their 4th birthday [32]. A
possible explanation is that most vulnerable subjects have
already had their kidneys scarred in infancy, and children
reaching 4 years without a scar are at minimal risk of
scarring in the future [33]. This may be because they never
had VUR, or they have VUR, but no compound papillae
and intrarenal reflux. In addition, there is evidence that
maturation does not lead to an increased resistance to
scarring after a UTI. It was demonstrated that adult pigs are
as vulnerable to scarring as piglets [34], and there have
been reports of typical reflux nephropathy lesions appearing
in transplanted mature human kidneys, both histologically
and on DMSA scanning [35]. It was also found in a
prospective study that the risk of renal scars after APN does
not diminish with age [36]. Therefore, it should be
recognized that progressive RN might occur in older
children with VUR and UTI, who had abnormal findings
in their initial DMSA scans.
Outcome of children with VUR and RN
Our understanding of the natural history of VUR was based
on old long-term follow-up studies that detected renal scars
with intravenous urography (IVU). Renal scars took months
or years after an APN to develop to a size that could be
readily detected with IVU. In recent studies, IVU has been
replaced by DMSA, which is significantly more sensitive to
detect focal kidney abnormalities. Obviously, the long-term
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outcome of these children might not be relevant to patients
with lesions detected by IVU [37]. Changes on the DMSA
scan were found in 86% of 76 children during APN.
However, 27% of the lesions resolved within 2 months after
the APN and 49% within 2 years [38]. Other sequential
studies, evaluating patients with an initially abnormal
DMSA scan, revealed that renal defects persisted as renal
scarring in 36%–52% of kidneys [20]. In addition, new
renal scarring developed in 25% of kidneys with VUR
compared with 37% without VUR [25]. Therefore, once
APN has occurred, ultimately renal scarring is independent
of the presence or absence of VUR.
In a recent retrospective cohort study, it was found that
after a long-term follow-up 2.8% of children with VUR had
a GFR <75 ml/min per 1.73 m2 in two consecutive
examinations, and the prevalence of hypertension was
2.7% [39]. There was no difference in progression to
chronic renal insufficiency between boys (3.8%) and girls
(2.4%). Although boys had a more severe pattern at
baseline, girls had a greater risk of dysfunctional voiding
and recurrent UTI during follow-up. The decline of renal
function occurred in those patients with severe bilateral
renal damage or in those children with contralateral primary
renal damage. The majority of these lesions are primarily
determined, and, probably, the appropriate management of
primary VUR could scarcely contribute to improving the
prognosis of these patients [39]. Data from various
registries have shown that between 5% and 12% of patients
entering end-stage renal disease programs have RN.
However, the total number of these patients is a small
percentage of all patients with RN. Therefore, only a very
small percentage of children with VUR and RN are at risk
to develop end-stage renal disease in adulthood [12]. In
addition, estimates of undesirable outcomes of RN in
adulthood, such as hypertension and end-stage renal
disease, are based on the mathematical product of proba-
bilities at several steps, each of which is subject to bias and
error.
Imaging techniques
There has been an ongoing debate for several years about the
most effective imaging strategy for children with UTI. Some
centers focus mainly on detection of renal damage using US
and/or DMSA. Other centers focus on the detection of VUR
using VCUG or RNC or voiding urosonography (VUS).
However, the majority of protocols recommend the complete
functional and morphological evaluation of the child’s
urinary tract. All these imaging techniques provide different
information about the kidneys and urinary tract (Fig. 2).
Therefore, integration of the data of the imaging results will
provide the appropriate information for optimal manage-
ment. In addition, the communication between radiologists
and clinicians is fundamental for the integration of the
imaging results with clinical and laboratory data leading to
the optimal management.
Urinary tract ultrasound and DMSA scan
US is a noninvasive technique with no ionizing radiation
and is generally accepted as the primary imaging method
for the evaluation of the kidneys and the bladder and the
assessment of pelvic and calyceal dilatation, but it offers
poor anatomical information about the urethra and the
ureters [40]. However, US is neither sensitive, nor specific
for detecting VUR [41]. It is of interest that 74% of
refluxing renal units had normal US and 28% of them had
VUR grade 3 or higher [42]. Indirect US signs, such as
thickening of the renal pelvic, ureteric or bladder wall, as
well as trabeculation or residual volume after voiding may
increase the detection rate for VUR to as high as 85%, but
still with a low specificity [40]. US findings, suggestive of
renal scarring, may be a focal thinning of the renal cortex
with or without indentation of the renal contour. In a
systematic review by Roebuck et al., the sensitivity of US
for scarring compared to DMSA ranged from 37% to
100%, and the specificity from 65% to 99% [43]. In another
recent study, it was also found that the US had good
specificity for the detection of renal scarring compared with
DMSA. However, the sensitivity was low [44]. It is not
clear that the additional sensitivity of DMSA translates
directly to additional information of clinical importance. On
the other hand, radiation exposure is an important limitation
of DMSA (Table 1), especially when it is repeated several
times. In addition, radionuclide studies are not as widely
available for infants and young children as other modalities.
Several pitfalls in the interpretation of the DMSA findings
have been reported. Uncomplicated simple duplex kidneys
may have greater uptake in the duplex kidneys or cause an
erroneous impression of a small poorly developed contra-
lateral kidney [45]. Similarly, a damaged duplex kidney
may have normal relative function. Duplex systems are not
always recognizable on DMSA scans. The relative function
of each kidney is also normal in patients with bilateral renal
damage. These pitfalls might be avoided when both a
DMSA and an US are performed.
In summary, US is an excellent modality for detecting
structural renal abnormalities. However, the use of US in
the detection of scarring remains controversial.
Voiding cystourethrography
VUR has been traditionally detected by VCUG. Recently,
digital and pulsed fluoroscopy have enabled a significant
reduction of the radiation dose and reliable documentation
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of the findings [46–49]. VCUG provides images with fine
anatomical detail, including the bladder and the urethra.
The most important limitation of VCUG is the radiation
exposure, particularly to the gonads [40, 50]. Furthermore,
catheterization is painful and not entirely without the risk of
iatrogenic infection. The incidence of post-VCUG infec-
tions was 6% to 22% in studies published in the 1970s.
However, it was recently documented that with a prophy-
laxis protocol, a low incidence of symptomatic UTI (1.7%)
was observed [51]. An alternative is to use suprapubic
VCUG to avoid this complication. However, it was
reported that suprapubic puncture took a little longer than
urethral catheterization and scored slightly worse for
discomfort. In addition, most families felt strongly that
urethral catheterization seemed safer and preferable to
suprapubic puncture [52].
Since VUR may be intermittent, the sensitivity in
detecting VUR can be improved with cyclic procedures,
i.e., filling the bladder and having the infant void around
the catheter two or more times [53–55]. Cyclic procedures
should only be used with RNC and VUS because of the
unacceptably high radiation burden in cyclic VCUG [53].
A plain abdominal radiography, performed before the
VCUG, may be helpful to provide some important
information by detecting small calculi, spinal or sacral
anomalies, bowel dilatation and stool retention [40].
Radionuclide cystourethrography
There are two methods of RNC. The first, direct RNC,
requires bladder catheterization and instillation of the
radionuclide. Indirect RNC does not need bladder catheter-
ization, but can only be performed in toilet-trained children,
following a dynamic renogram, after intravenous injection
Table 1 Effective radiation dose of imaging techniques
Imaging Effective dose (mSV)
Voiding cystourethrography 0.14–1.56 [48]
Direct radionuclide cystography 0.04–0.09 [92]
DMSA scan 1.10–1.18 [93]
Fig. 2 Radiological imaging of
a 7-year-old girl with a history
of acute pyelonephritis. a Void-
ing cystourethrography shows
bilateral vesicoureteral reflux
(VUR) grade III. b Contrast-
enhanced harmonic voiding
urosonography (VUS) (trans-
verse section in prone position)
shows also VUR grade III. The
same image was found in VUS
on the left kidney (not shown).
c Ultrasound of the right kidney
reveals irregularity of renal out-
line and focal thinning of renal
cortex in the upper pole, find-
ings compatible with scar.
d Posterior view of 99mTc-
dimercaptosuccinic acid
(DMSA) scan 6 months after an
acute pyelonephritis shows a
focal defect in radiotracer uptake
of the upper pole on the right
kidney, indicating the presence
of a renal scar
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of Tc-99m MAG3 or DTPA [41]. RNC provides less
gonadal radiation (Table 1) and continuous monitoring, but
the anatomic details are poor [40, 50].
With VCUG and direct RNC, both the filling and the
micturition phase can be studied, whereas only the micturition
phase may be studied with indirect RNC [56]. VUR was
demonstrated only in the filling phase in some studies.
Therefore, it was suggested that with indirect RNC a
significant number of children with VUR will not be
diagnosed [57]. In contrast, a high sensitivity of indirect
RNC compared with direct RNC was documented by others
[58], and it was recommended that those children >3 years of
age who are toilet trained should undergo indirect RNC [59].
Voiding urosonography
Contrast-enhanced voiding urosonography (VUS) with
microbubbles containing contrast medium has comparable
diagnostic accuracy to VCUG particularly for dilating VUR
[60–63] and compared to direct RNC [64]. In addition,
low-grade VUR has become reliably detectable with the use
of contrast harmonic imaging [53, 65, 66]. Cyclic VUS
detected 25% more VURs than the conventional (one cycle
only) VUS [67]. Recently, a second cycle of contrast-
enhanced harmonic VUS with no added additional dose of
contrast medium has been reported to disclose significantly
more cases of VUR at no additional cost for the
examination [68]. The disadvantages of VUS are the less
accurate grading and the poor anatomical information of the
ureters and the urethra [40]. In addition, the longer
examination time required for the VUS is an obstacle.
However, exposure of the child to radiation is completely
avoided, which is even more important in those children
who must present for several follow-ups [63].
Comparisons among VUS, VCUG and RNC have
shown a high concordance regarding the diagnosis of
VUR. VUS was found to be more sensitive when compared
to VCUG. Moreover, the refluxes missed by VCUG are
predominantly of higher grade and thus clinically more
important than those missed by VUS [69].
Magnetic resonance urography (MRU)
MRU is a new technique for evaluating the urinary tract,
and it is expected to replace traditional diagnostic methods,
because it does not use ionizing radiation [40, 70].
Gadolinium-enhanced dynamic MRU allows better assess-
ment of the urinary tract in neonates and infants than the
US and IVU, with additional functional information [71].
MRU thus has the potential to replace IVU for many
indications. In a recent study, post-gadolinium magnetic
resonance imaging was compared with DMSA [72].
Sensitivity and specificity of magnetic resonance imaging
in the detection of pyelonephritic lesions were found to be
91% and 89%, respectively, and there was no statistically
significant difference in lesion detection between these
modalities. Moreover, magnetic resonance imaging was
superior in discriminating acute pyelonephritic lesions and
permanent renal damage in early stages of disease [72].
MRU, with the use of optimal imaging sequences, correctly
depicts anatomy and allows assessment of the urinary tract
better than US and IVU, with additional angiographic and
functional information. However, the use of MRU is
presently restricted because it is expensive, not widely
available, time-consuming and requires sedation of the
young child [40]. MRU might become the imaging
modality of the future, but our experience is quite limited
today.
Selection criteria for imaging methods in the diagnosis
of VUR
The selection of an imaging method for VUR depends
mainly on the patient population (age and gender).
However, individual experience, the equipment available
locally, as well as health care costs may influence the
decision of the selected imaging method for the diagnosis
of VUR. Many centers recommend VCUG as the first
examination modality for VUR in boys, with a specific
request for urethral and/or bladder imaging, and for severe
antenatal hydronephrosis and abnormal kidney on renal US
or DMSA scan [40, 50]. However, it is suggested that RNC
might replace VCUG with the exception of male infants
with gross bladder and/or bilateral pelviureteric dilatation
by sonography, suggesting posterior urethral valves [73].
On the other hand, it is generally accepted that the primary
indications for RNC or VUS are follow-up examinations
and the screening of asymptomatic siblings of patients with
VUR [40, 50, 69].
Initial work-up in high risk groups
The prevalence of VUR is increased in selected groups,
such as children with UTI, first-degree relatives of patients
with VUR and children with antenatal hydronephrosis [74].
This was the reason for the development of recommenda-
tions for the investigation for VUR in these groups.
Children with a first upper UTI
The guidelines of the American Academy of Pediatrics for
all febrile children having their first UTI below 2 years of
age include a combination of US and VCUG or RNC [75].
There is no benefit in delaying the performance of VCUG
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or RNC as long as the child is free of infection and bladder
irritability is absent [75]. Swedish and United Kingdom
guidelines are similar, but also include a DMSA [76, 77].
However, these guidelines do not reflect changing trends in
the evaluation of children with UTIs. Recently, it has been
suggested that a DMSA scan in these patients may replace
VCUG as a first investigation, based on the fact that a
normal DMSA scan excludes VUR of clinical significance
[29]. VCUG is recommended only in patients with renal
lesions on DMSA scan or recurrent febrile UTIs [28, 29]. It
has also been suggested that DMSA should be performed
within a few days after the diagnosis of APN, as the
number of positive studies decreases rapidly following the
initiation of antibiotic therapy [78].
It has to be pointed out that false-positive urine cultures
are frequent and should be appropriately ruled out to protect
children with a false diagnosis of UTI from being subjected
to non-justified investigations. For this reason, the Amer-
ican Academy of Pediatrics recommended that if an infant
or young child 2 months to 2 years of age with unexplained
fever is assessed as being sufficiently ill to warrant
immediate antimicrobial therapy, a urine specimen should
be obtained by suprapubic aspiration or transurethral
bladder catheterization; the diagnosis of UTI cannot be
established by a culture of urine collected in a bag [75].
However, some children with clinical and laboratory
findings of APN have negative urine cultures, because of
inappropriate use of antibiotics. Levtchenko et al. have
shown that APN can be diagnosed in these patients with the
findings of DMSA [78].
It is fundamental that infections of the upper urinary tract
should be distinguished from UTIs without parenchymal
involvement. The diagnosis of APN in children with febrile
UTIs on the basis of clinical and laboratory observations is
unreliable. Therefore, an acute DMSA scan can be very
useful in diagnosing APN and for the identification of
patients at risk for subsequent renal scarring [20]. It is also
feasible to differentiate the defects of APN and permanent
renal scarring with an acute DMSA scan. APN is
characterized by focal areas of diminished uptake with a
normal renal contour. In contrast, permanent renal defects
appear as focal or generalized areas of diminished
radioisotope uptake with thinning or flattening of the
cortex, and in other cases renal scars appear as classic
discrete wedge-shaped parenchymal defects. This differen-
tiation becomes more difficult in cases of APN with pre-
existent renal scarring [20]. The major advantage of an
acute DMSA is the identification of primary lesions and
their differentiation from secondary lesions, but this is not
always possible [20].
The use of DMSA for early investigation of young
febrile children with their first UTI is not generally
accepted. Recently, a questionnaire related to DMSA in
children with UTI was submitted to 30 experts. Only 58%
of the experts are systematically performing this examina-
tion during the acute phase of infection [79]. The major
criticism is that the findings of an acute DMSA may not
change the management of individual cases. A normally
sized kidney on US with or without VUR has a very low
risk for cumulative damage by UTIs resulting in CRI. Most
children with APN will show abnormalities that may not
have long-term implications. In addition, a DMSA has a
more than negligible radiation load, especially when
repeated several times. Some centers recommend a VCUG
or RNC after a febrile UTI and recommend that DMSA
should be performed 6 months after the last UTI in all
patients with VUR, and only in those patients without VUR
who are considered at higher risk for renal abnormality, i.e.,
with at least two febrile UTIs or one febrile UTI and
delayed antibiotic treatment [17].
Guidelines for older children differ between centers and
are not evidence based. US and DMSA are usually used for
the investigation of these patients, and VCUG or preferably
RNC is used only in children with abnormalities seen on
DMSA or US, or those with antenatal hydronephrosis or a
family history of VUR. It is important to advise the families
to maintain a high suspicion for further UTI. Obviously all
children with recurrent febrile UTIs should be investigated
with a VCUG.
Poor compliance to the recommendations by the Amer-
ican Academy of Pediatrics for a first UTI in children was
found in a retrospective cohort study using Washington
State Medicaid data. Actually, less than 50% of children
who were diagnosed with a UTI in their 1st year of life
received either timely anatomic imaging or imaging for
VUR [80]. Recently, the evidence for routine VCUG has
been increasingly questioned, and possibly this was one of
the reasons for the poor compliance in this study. In recent
years there has been a tendency to neglect important data
that has accumulated from the experience of many experts
over the last 4 decades. However, the absence of evidence
is not evidence of the absence.
In conclusion, there are two strategies for the initial
investigation of children below 2 years of age with a first
febrile UTI. The first recommends a DMSA scan and a
US, and only children with renal lesions on DMSA scan
or with recurrent febrile UTIs should be evaluated with a
VCUG or RNC. It is usually feasible to distinguish
primary and secondary renal lesions with this approach.
This is the preferred procedure in centers with a legitimate
academic interest. The alternative strategy adopted by
many clinically oriented pediatric nephrologists is the use
of a VCUG or RNC and a US for the initial investigation
of these patients. A DMSA scan is recommended in a
later stage only in patients with VUR or with recurrent
UTIs.
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First-degree relatives of patients with VUR
The incidence of sibling VUR is significantly higher
compared with the general population, and most studies
advocate screening asymptomatic siblings of patients with
VUR [81]. VUR was found in 32% of 570 siblings in a
review from 11 publications [6]. However, VUR was
greater than grade III in only 2%, and renal abnormalities
were identified in 3% of siblings. These data do not prove
that screening and treating asymptomatic siblings decrease
infectious renal scarring [6]. In another study, a group of
117 asymptomatic siblings of known patients with VUR
older than 5 years as well as younger children whose
parents refused VCUG were screened with US. A VCUG
was performed on children with US abnormalities (discrep-
ancy in renal size, renal scarring or hydronephrosis, or a
change in the size of the renal pelvis). Only nine patients
had abnormal US, and VUR was diagnosed in five of them
[82]. Obviously the incidence of VUR in the remaining 108
patients is not known, since the absence of abnormal
findings in US does not exclude VUR. VCUG screening is
probably unnecessary in siblings older than 5 years, since
there is evidence that they have a lower incidence of VUR
compared with younger children [83, 84].
Young asymptomatic siblings should be investigated
with a VCUG or RNC. US might be a reliable alternative to
invasive VCUG screening in older children. However,
studies of control groups that consider sibling age are still
needed to determine the benefit of screening asymptomatic
siblings [6]. Families of these children should be advised to
maintain a high suspicion for UTIs, and the treatment of
diagnosed UTIs should start immediately.
Children with antenatal hydronephrosis
The wider use of antenatal US resulted in an increased
diagnosis of abnormalities of the urinary tract. Fetal renal
pelvis dilatation is the most common abnormality, observed
in 4.5% of pregnancies [85]. Significantly more dilating
VUR was found in neonates with UTIs detected within the
first 4 postnatal weeks compared with antenatally diagnosed
patients (53% versus 29%). The incidence of congenital
renal lesions was 14% in both groups. Focal renal scars
developed during follow-up in 19% of renal units with VUR
of grades IV and V, exclusively in the postnatal patient
group [86]. Findings were similar in the study by Garin et
al., who documented that only patients with grade IV-V
VUR are at high risk for serious adverse outcome [87].
Infants with a history of fetal renal pelvis dilatation should
have a postnatal US after the 1st week to avoid the false-
negative results that occur in this period [88]. During the last
decade, improved US technology has led to a significant
increase of the antenatal identification of newborns with a
small renal pelvis dilatation and the postnatal diagnosis of
infants with low-grade VUR. In a recent study, a VCUG
was performed only in infants with antenatal hydronephrosis
and abnormal neonatal US findings. This policy resulted in
decreasing the number of VCUG by 50% [5]. Using these
restrictive recommendations, low-grade VUR was diag-
nosed in 74% of cases and a high rate of spontaneous
resolution occurred at 24 months [5].
In conclusion, only infants with a history of fetal renal
pelvis dilatation and postnatal hydronephrosis should be
investigated with a VCUG or RNC. However, occasional
cases of low-grade VUR could be missed with this
approach, and all parents should be informed that if their
child develops a fever of unknown origin, then the urine
should be investigated for infection as soon as possible.
Timing of follow-up in children with VUR
Since the majority of children will have resolution of VUR
over time [89], most of them initially are treated with long-
term antibiotic prophylaxis, and a periodic VCUG is
performed until the spontaneous resolution of VUR [90].
However, no clear guidelines exist regarding the timing of
follow-up by VCUGs. Recently, a follow-up with VCUG
every 2 years in children with mild VUR and every 3 years
in children with moderate/severe VUR has been suggested.
With these recommendations, the number of VCUGs and
the cost will be reduced significantly [91].
Conclusions
Early identification of patients at risk for the development of
acquired renal scarring (i.e., infants and young children after
the first UTI or with antenatal diagnosis of hydronephrosis or
siblings of patients with VUR) is the goal of the diagnostic
imaging. This risk is significant if dilating VUR is not
detected until the first UTI. Diagnostic delay, inappropriate
treatment and dysfunctional voiding are important factors for
the development of RN. However, the decline of renal
function occurs mainly in patients with severe bilateral renal
damage, usually with congenital RN, and UTIs have an
important role in the deterioration of these lesions. There-
fore, the focus of investigation should be based on what is
happening to the kidney, and an early DMSA scan can
identify those children who are at risk for pyelonephritic
damage and subsequent renal scarring. With this approach,
the number of children who need to be investigated with a
VCUG will be reduced. However, this approach is not
generally accepted, and the effect of early identification of
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renal damage on outcome is still unclear. Less invasive
techniques with less radiation load should be used, and
targeted imaging guidelines should be developed based on
evidence from appropriate long-term studies. Our attention
should not only focus on the strategies of imaging, but also
on advising the parents of children at risk of developing
permanent renal damage with simple preventive information.
Multiple choice questions (answers appear following
reference list)
(More than one answer might be correct)
1. The prevalence of vesicoureteral reflux (VUR) is
increased among:
a. Children with urinary tract infections (UTI)
b. Siblings with known VUR
c. Monozygotic twins
d. Neonates with antenatal diagnosis of hydronephrosis
e. Infants with UTI, compared to older children
2. Which of the following are true for renal scarring
caused by UTI?
a. It is a risk factor for long-term complications such
as hypertension and impaired renal function
b. It occurs only in children with VUR
c. DMSA scan is more sensitive than intravenous
urography (IVU) to detect renal damage
d. Renal scars take months after an acute pyelone-
phritis to be detected with IVU.
e. Recurrent UTIs increase the risk for renal scarring
3. Which of the following are true of primary reflux
nephropathy?
a. Boys are more often affected
b. The kidneys are normal at birth
c. Renal damage is the result of neonatal UTIs
d. VUR is usually of high grade
e. None of the above
4. Which of the following are indirect ultrasound signs,
indicating VUR?
a. Pelvic dilatation
b. Thickening of the renal pelvic, ureteric or bladder
wall
c. Residual volume after voiding
d. Increased renal size
e. None of the above
5. Febrile children with UTI below 2 years of age should
be evaluated with:
a. An IVU and VCUG
b. A VCUG
c. An ultrasound
d. A DMSA scan
e. An ultrasound and DMSA scan
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